Hansoh Pharmaceutical Group company profile

3692 · HKEX · HKD

Compare Hansoh Pharmaceutical Group
$32.42Change from previous close: −2.99%Absolute change: −$1.00

Close · November 18, 2026

Company profile

Hansoh Pharmaceutical Group has 9,643 employees and is headquartered in Shanghai, China.

Founded in 1995 and headquartered in Shanghai, Hansoh Pharmaceutical Group Company Limited is an investment holding company that develops, manufactures and sells medicines across China. Its products address anti-infection, central nervous system, oncology, metabolic and autoimmune conditions, under brands such as Ameile, Hengmu and XINYUE. Licensing deals with GlaxoSmithKline, Biotheus and Merck Sharp & Dohme cover lung cancer and metabolic candidates, and a separate collaboration with Roche targets antibody-drug conjugate programs.

In the fiscal year ended December 2025, revenue stood at CNY 15.0 billion, up 22.6% on the prior year, while net profit reached CNY 5.6 billion. The company reports 9,643 employees.

Company facts

Industry
Drug Manufacturers - Specialty & Generic
Headquarters
287 Xiangke Road, 201210, Shanghai
Employees
9,643
Chief executive
Huijuan Zhong
Founded
1995
Fiscal year
January - December
Listing
3692 · HKEX
Indices
Hang Seng
Currency
HKD
ISIN
KYG549581067

Hansoh Pharmaceutical Group and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
Hansoh Pharmaceutical Group3692Hong Kong SAR China$25.82B9,64337.3%27.6
Divi's LaboratoriesDIVISLABIndia$31.67B11,56534.0%88.0
Torrent PharmaceuticalsTORNTPHARMIndia$19B18,25822.2%78.9
Shionogi4507Japan$17.03B6,22331.6%11.4
PharmaEssentia6446Taiwan$16.43B13140.3%59.4
Yunnan Baiyao Group000538China$15.07B9,28611.2%19.3

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Hansoh Pharmaceutical Group with its competitors